CVI Accepts, published online ahead of print on 18 July 2007
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cook, E.
Right arrow Articles by Fries, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cook, E.
Right arrow Articles by Fries, B. C.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00183-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Measurement of Staphylococcal enterotoxin B in serum and culture supernatant with a Capture Elisa

E. Cook, X. Wang, N. Robiou, and B. C. Fries

Departments of Medicine, Microbiology and Immunology at Albert Einstein College of Medicine Bronx New York Fordham University Bronx, New York


arrow
Abstract

Staphylococcal enterotoxin B (SEB) is a select agent because it is a potent mitogen that elicits life-threatening polyclonal T-cell proliferation and cytokine production at very low concentrations. Efforts are in progress to develop therapeutic reagents and vaccines that neutralize or prevent the devastating effects of this toxin. Because of rapid binding to in vivo receptors, this toxin is difficult to detect in serum. This rapid binding also constitutes a major challenge for the development of effective therapeutic reagents that can neutralize the effects of the toxin in vivo. We have developed a highly sensitive capture ELISA that detects SEB in body fluids at very low levels. With this assay, peak serum levels of SEB and renal clearance can be measured in mice. After either oral ingestion or nasal inhalation of SEB by mice, this assay documents transcytosis of SEB across the mucosal membranes into serum within 2 hours. Furthermore, this assay was used to compare SEB levels in different murine models for SEB induced lethal shock and demonstrated that co-administration of toxin enhancing chemicals such as D-galactosamine and LPS can alter peak serum levels of SEB. Hence, this assay is a potentially useful tool for the study of SEB pharmacokinetics and the effects of potential therapeutic reagents on SEB serum levels.




This article has been cited by other articles:

  • Varshney, A. K., Mediavilla, J. R., Robiou, N., Guh, A., Wang, X., Gialanella, P., Levi, M. H., Kreiswirth, B. N., Fries, B. C. (2009). Diverse Enterotoxin Gene Profiles among Clonal Complexes of Staphylococcus aureus Isolates from the Bronx, New York. Appl. Environ. Microbiol. 75: 6839-6849 [Abstract] [Full Text]